Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6XRX

Crystal structure of the mosquito protein AZ1 as an MBP fusion

Summary for 6XRX
Entry DOI10.2210/pdb6xrx/pdb
Related PRD IDPRD_900001
DescriptorMaltose/maltodextrin-binding periplasmic protein, Mosquito protein AZ1, alpha-D-glucopyranose-(1-4)-alpha-D-glucopyranose, SODIUM ION, ... (6 entities in total)
Functional Keywordsmosquito, fatty acids, lipids, anti-viral, lipid binding protein
Biological sourceEscherichia coli
More
Total number of polymer chains1
Total formula weight61850.49
Authors
Pedersen, L.C.,Mueller, G.A.,Foo, A.C.Y. (deposition date: 2020-07-14, release date: 2021-03-24, Last modification date: 2023-10-18)
Primary citationFoo, A.C.Y.,Thompson, P.M.,Chen, S.H.,Jadi, R.,Lupo, B.,DeRose, E.F.,Arora, S.,Placentra, V.C.,Premkumar, L.,Perera, L.,Pedersen, L.C.,Martin, N.,Mueller, G.A.
The mosquito protein AEG12 displays both cytolytic and antiviral properties via a common lipid transfer mechanism.
Proc.Natl.Acad.Sci.USA, 118:-, 2021
Cited by
PubMed Abstract: The mosquito protein AEG12 is up-regulated in response to blood meals and flavivirus infection though its function remained elusive. Here, we determine the three-dimensional structure of AEG12 and describe the binding specificity of acyl-chain ligands within its large central hydrophobic cavity. We show that AEG12 displays hemolytic and cytolytic activity by selectively delivering unsaturated fatty acid cargoes into phosphatidylcholine-rich lipid bilayers. This property of AEG12 also enables it to inhibit replication of enveloped viruses such as Dengue and Zika viruses at low micromolar concentrations. Weaker inhibition was observed against more distantly related coronaviruses and lentivirus, while no inhibition was observed against the nonenveloped virus adeno-associated virus. Together, our results uncover the mechanistic understanding of AEG12 function and provide the necessary implications for its use as a broad-spectrum therapeutic against cellular and viral targets.
PubMed: 33688047
DOI: 10.1073/pnas.2019251118
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.95 Å)
Structure validation

227344

PDB entries from 2024-11-13

PDB statisticsPDBj update infoContact PDBjnumon